[Webinar held on April 4th and April 13th] Trends and future vision of the data-driven market in the medical and pharmaceutical fields-New solutions utilizing AI and industry game changers-
In the medical field such as the spread of mobile terminals such as smartphones, the spread of communication-type apps such as SNS, the spread of electronic medical records, the expansion of telemedicine, and the utilization of real-world data amid the progress of the information-oriented society worldwide. In Japan, the introduction of AI and the trend of digitalization are expanding more rapidly than ever before.On the other hand, in addition to the progress of AI technology, there are problems with software and communication networks, and complicated regulations unique to the industry, so the current situation is that the number of AI solutions that have been put into practical use in the medical and pharmaceutical fields is still limited. ..
In this seminar, in addition to the latest trends in the data-driven market in the medical industry, we will introduce the development of program medical devices centered on AI and the future image of the industry, based on specific examples.
・ [Recorded distribution] April 2022, 4 (Thursday) 14: 12-15: 12:https://lifescience.fronteo.com/ba/knobbe/webinar0414
◆ Theme: Trends and future vision of the data-driven market in the medical / pharmaceutical field-New solutions utilizing AI and industry game changers-
◆ Date:
・ [Recorded distribution] April 2022, 4 (Thursday) 14: 12-15: 12
·Pharmaceutical companies
・ Healthcare / medical related companies
・ Digital health related companies
・ Health food goods company
・ Long-term care-related businesses
Masato Takahashi
After joining Astellas Pharma (formerly Fujisawa Pharmaceutical), after working in a sales position (MR), became a product manager at the sales headquarters.Experience new launches and expanded indications of various products from the primary area to the specialty area (organ / bone marrow transplantation, autoimmune diseases, rare diseases, respiratory diseases, allergic diseases, etc.).After that, as a new product planning, he was involved in the evaluation of product marketability and business feasibility, and from 2014, he experienced the formulation of business plans and the design and operation of a dedicated organization as the director of the transplant immunology area. Joined SymBio Pharmaceuticals Limited, a pharmaceutical bio-venture in 2016.He was involved in the launch of the blood cancer business as a marketing head, and later became the general manager of the company's sales and marketing division.In addition to building an in-house sales (pharmaceutical manufacturer / distributor) system specializing in the blood field and building a digital system, he is engaged in licensing business and alliance management.
Participated in FRONTEO in 2019, planning and directing business strategy for medical device development and launch using the world's first language analysis AI. Build a new business model for drug discovery and drug repositioning that utilizes AI technology. Appointed executive officer in 2021. Aiming to become the global leader as a life science company that integrates AI and medical care.
Articles in the same category
[Webinar held on 7/14] AI-based support tool for new strategy formulation "Word ATLAS" -Non-biased competitive analysis and visualization of KOL trends-
[7/14 Webinar] The latest information on the enforcement and procurement of US patents
[Webinar held on 7/7] Labor issues associated with remote work-Points of labor management and investigation in case of emergency-
[6/29 held webinar] AI visualizes customer's voice! The 2nd VOC utilization course will be held due to its popularity!
FRONTEO AI Innovation Forum 2022 held
-Realistic problem-solving that can be realized only with natural language AI Fairness of information society created by innovative AI-
[Webinar held on 6/30] Natural language AI predicts disaster risk-Introducing disaster mitigation DX in the manufacturing and construction industries-
[6/29 held webinar] Introducing new functions of drug discovery support AI "Cascade Eye" that visualizes and structures relationships between complex genes and molecules
[Webinar held on June 6] Reiwa June 23, 4th Amendment Public Interest Whistleblower Protection Law Enforcement
[Webinar held on 6/14] <Peaceful compliance measures commentary series 3rd> Site of corporate culture verification
[Webinar held on 6/15] New AI solution "liGALILEO" for multifaceted scientific evaluation of target molecules-Realizing efficient drug discovery development-
Commonly viewed articles
Chugai Pharmaceutical Co., Ltd. has been posted as an introductory user.
FRONTEO's finance in NHK Close-up Gendai + "How to protect your assets? -Prescription for the ultra-low interest rate era-" broadcast on 10/30 ...
Comprehensive support for marriage activities using artificial intelligence KIBIT at the NHK special "Artificial Intelligence Angel or Devil 9" broadcast on 15/2018 ...
Aiming to realize a society where everyone can live in their own way
